Logo image of BW

BABCOCK & WILCOX ENTERPR (BW) Stock Fundamental Analysis

NYSE:BW - New York Stock Exchange, Inc. - US05614L2097 - Common Stock - Currency: USD

1.15  -0.05 (-4.17%)

After market: 1.22 +0.07 (+6.09%)

Fundamental Rating

1

Taking everything into account, BW scores 1 out of 10 in our fundamental rating. BW was compared to 93 industry peers in the Electrical Equipment industry. BW has a bad profitability rating. Also its financial health evaluation is rather negative. BW does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BW has reported negative net income.
In the past year BW has reported a negative cash flow from operations.
BW had negative earnings in 4 of the past 5 years.
In the past 5 years BW always reported negative operating cash flow.
BW Yearly Net Income VS EBIT VS OCF VS FCFBW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M

1.2 Ratios

BW has a Return On Assets of -9.25%. This is comparable to the rest of the industry: BW outperforms 58.70% of its industry peers.
The Return On Invested Capital of BW (3.02%) is better than 70.65% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BW is significantly below the industry average of 10.23%.
The 3 year average ROIC (2.71%) for BW is below the current ROIC(3.02%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -9.25%
ROE N/A
ROIC 3.02%
ROA(3y)-9.65%
ROA(5y)-10.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.71%
ROIC(5y)2.91%
BW Yearly ROA, ROE, ROICBW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K

1.3 Margins

With a decent Operating Margin value of 2.21%, BW is doing good in the industry, outperforming 67.39% of the companies in the same industry.
In the last couple of years the Operating Margin of BW has declined.
BW has a Gross Margin of 23.73%. This is comparable to the rest of the industry: BW outperforms 57.61% of its industry peers.
In the last couple of years the Gross Margin of BW has declined.
Industry RankSector Rank
OM 2.21%
PM (TTM) N/A
GM 23.73%
OM growth 3Y-8.73%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.53%
GM growth 5YN/A
BW Yearly Profit, Operating, Gross MarginsBW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BW is destroying value.
Compared to 1 year ago, BW has more shares outstanding
The number of shares outstanding for BW has been increased compared to 5 years ago.
The debt/assets ratio for BW is higher compared to a year ago.
BW Yearly Shares OutstandingBW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
BW Yearly Total Debt VS Total AssetsBW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -1.16, we must say that BW is in the distress zone and has some risk of bankruptcy.
BW has a Altman-Z score of -1.16. This is in the lower half of the industry: BW underperforms 64.13% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.16
ROIC/WACC0.54
WACC5.6%
BW Yearly LT Debt VS Equity VS FCFBW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M

2.3 Liquidity

BW has a Current Ratio of 1.78. This is a normal value and indicates that BW is financially healthy and should not expect problems in meeting its short term obligations.
BW has a Current ratio of 1.78. This is comparable to the rest of the industry: BW outperforms 47.83% of its industry peers.
BW has a Quick Ratio of 1.39. This is a normal value and indicates that BW is financially healthy and should not expect problems in meeting its short term obligations.
BW has a Quick ratio (1.39) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.39
BW Yearly Current Assets VS Current LiabilitesBW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

1

3. Growth

3.1 Past

BW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -141.14%.
BW shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.50%.
Measured over the past years, BW shows a decrease in Revenue. The Revenue has been decreasing by -1.22% on average per year.
EPS 1Y (TTM)-141.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105%
Revenue 1Y (TTM)-16.5%
Revenue growth 3Y20.84%
Revenue growth 5Y-1.22%
Sales Q2Q%-12.32%

3.2 Future

BW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.77% yearly.
Based on estimates for the next years, BW will show a decrease in Revenue. The Revenue will decrease by -5.22% on average per year.
EPS Next Y86.08%
EPS Next 2Y41.26%
EPS Next 3Y29.77%
EPS Next 5YN/A
Revenue Next Year-17.81%
Revenue Next 2Y-10.71%
Revenue Next 3Y-5.22%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BW Yearly Revenue VS EstimatesBW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
BW Yearly EPS VS EstimatesBW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -20 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BW Price Earnings VS Forward Price EarningsBW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

BW's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BW is cheaper than 77.17% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.56
BW Per share dataBW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

BW's earnings are expected to grow with 29.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.26%
EPS Next 3Y29.77%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BABCOCK & WILCOX ENTERPR

NYSE:BW (2/21/2025, 8:04:42 PM)

After market: 1.22 +0.07 (+6.09%)

1.15

-0.05 (-4.17%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)03-11 2025-03-11/amc
Inst Owners77.45%
Inst Owner Change2.38%
Ins Owners4.26%
Ins Owner Change-0.45%
Market Cap108.47M
Analysts81.67
Price Target4.72 (310.43%)
Short Float %2.56%
Short Ratio2.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.13
Dividend Growth(5Y)N/A
DP-24.95%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1666.99%
Min EPS beat(2)-3783.5%
Max EPS beat(2)449.52%
EPS beat(4)1
Avg EPS beat(4)-1276.14%
Min EPS beat(4)-3783.5%
Max EPS beat(4)449.52%
EPS beat(8)1
Avg EPS beat(8)-737.95%
EPS beat(12)2
Avg EPS beat(12)-512.39%
EPS beat(16)6
Avg EPS beat(16)-334.78%
Revenue beat(2)0
Avg Revenue beat(2)-8.06%
Min Revenue beat(2)-11.29%
Max Revenue beat(2)-4.84%
Revenue beat(4)0
Avg Revenue beat(4)-8.14%
Min Revenue beat(4)-13.93%
Max Revenue beat(4)-2.5%
Revenue beat(8)3
Avg Revenue beat(8)-0.86%
Revenue beat(12)5
Avg Revenue beat(12)-0.71%
Revenue beat(16)8
Avg Revenue beat(16)1.38%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-103.7%
EPS NQ rev (3m)-101.92%
EPS NY rev (1m)0%
EPS NY rev (3m)-193.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-22.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 15.56
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-1.03
FCFYN/A
OCF(TTM)-0.93
OCFYN/A
SpS9.31
BVpS-2.16
TBVpS-3.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.25%
ROE N/A
ROCE 3.82%
ROIC 3.02%
ROICexc 3.22%
ROICexgc 4.16%
OM 2.21%
PM (TTM) N/A
GM 23.73%
FCFM N/A
ROA(3y)-9.65%
ROA(5y)-10.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.71%
ROIC(5y)2.91%
ROICexc(3y)3.51%
ROICexc(5y)3.64%
ROICexgc(3y)5.81%
ROICexgc(5y)5.57%
ROCE(3y)3.44%
ROCE(5y)8.52%
ROICexcg growth 3Y8.01%
ROICexcg growth 5YN/A
ROICexc growth 3Y0.31%
ROICexc growth 5YN/A
OM growth 3Y-8.73%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.53%
GM growth 5YN/A
F-Score3
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 13.24
Cap/Depr 51.43%
Cap/Sales 1.07%
Interest Coverage 0.57
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.39
Altman-Z -1.16
F-Score3
WACC5.6%
ROIC/WACC0.54
Cap/Depr(3y)46.1%
Cap/Depr(5y)40.64%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105%
EPS Next Y86.08%
EPS Next 2Y41.26%
EPS Next 3Y29.77%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.5%
Revenue growth 3Y20.84%
Revenue growth 5Y-1.22%
Sales Q2Q%-12.32%
Revenue Next Year-17.81%
Revenue Next 2Y-10.71%
Revenue Next 3Y-5.22%
Revenue Next 5YN/A
EBIT growth 1Y-11.38%
EBIT growth 3Y10.29%
EBIT growth 5YN/A
EBIT Next Year239.91%
EBIT Next 3Y62.58%
EBIT Next 5YN/A
FCF growth 1Y-18.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.37%
OCF growth 3YN/A
OCF growth 5YN/A